Antagonism of the discriminative stimulus effects of (+)-7-OH-DPAT by remoxipride but not PNU-99194A

Pharmacology Biochemistry and Behavior

Volumn 68, Issue 3, 2001, Pages 371-377

  Christian, April J ^a   Goodwin, Amy K ^a   Baker, Lisa E ^a  

^a WESTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

(+) 7 OH DPAT; D2 receptors; D3 receptors; Drug discrimination; PNU 99194A; Rats; Remoxipride

Indexed keywords

2 DIPROPYLAMINO 5,6 DIMETHOXYINDAN; 2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; COCAINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR STIMULATING AGENT; LIGAND; PD 152255; PRAMIPEXOLE; PSYCHOSTIMULANT AGENT; REMOXIPRIDE; SODIUM CHLORIDE; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG SELECTIVITY; INSTRUMENTAL CONDITIONING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STIMULUS GENERALIZATION; STIMULUS RESPONSE;

ANIMALS; BENZIMIDAZOLES; DISCRIMINATION (PSYCHOLOGY); DISCRIMINATION LEARNING; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENERALIZATION, STIMULUS; INDANS; MALE; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; REMOXIPRIDE; TETRAHYDRONAPHTHALENES;

EID: 0035017982     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(00)00470-6     Document Type: Article

References (22)

1. Acri JB, Carter S, Geter-Douglass B, Dijkstra D, Wikstrom H, Katz J, Witkin J. Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands. Eur J Pharmacol 1995;281:R7-9.
2. Baker LE, Miller ME, Svensson KA. Assessment of discriminative stimulus effects of the D3 dopamine antagonist PNU-99194A in rats: comparison with psychomotor stimulants. Behav Pharmacol 1997;8:243-52.
3. Baker LE, Svensson KA, Garner KJ, Goodwin AK. The dopamine D3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for D-amphetamine or cocaine. Eur J Pharmacol 1998;358:101-9.
4. Baker LE, Hood CA, Heidema AM. Assessment of D3 vs. D2 receptor mediation of the discriminative stimulus effects of (+)-7-OH-DPAT in rats. Behav Pharmacol 1999;10:717-22.
5. Bevins RA, Klebaur JE, Bardo MT. 7-OH-DPAT has D-amphetamine-like discriminative stimulus properties. Pharmacol Biochem Behav 1997;38(2):485-90.
6. Burris KD, Pacheco MA, Filtz TM, Kung M-P, Kung HF, Molinoff PB. Lack of discrimination by agonists for D2 and D3 receptors. Neuropsychopharmacology 1995;12:335-45.
7. Caine SB, Koob GF. Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat. Behav Pharmacol 1995;6:333-47.
8. Civelli O, Bunzow JR, Grandy DK, Zhou Q-Y, Van Toi HM. Molecular biology of the dopamine receptor. Eur J Pharmacol 1991;207:277-86.
9. Damsma G, Bottema T, Westerink BC, Tepper PG, Dijkstra D, Pugsley TA, MacKenzie RG, Heffner TG, Wilkstrom H. Pharmacological aspects of A-(+)-7-OH-DPAT, a putative dopamine D3 ligand. Eur J Pharmacol 1993;249:R9.
10. 3 agonist 7-OH-DPAT. Pharmacol Biochem Behav 2000;65:31-4.
11. Extance K, Goudie AJ. Inter-animal olfactory cues in operant drug discrimination procedures in rats. Psychopharmacology 1981;91:67-73.
12. Garner KJ, Baker LE. Analysis of D2 and D3 receptor-selective ligands in rats trained to discriminate cocaine from saline. Pharmacol Biochem Behav 1999;64(2):373-8.
13. Lamas X, Negus SS, Nader MA, Mello NK. Effects of the putative dopamine D3 receptor agonist 7-OH-DPAT in rhesus monkeys trained to discriminate cocaine from saline. Psychopharmacology 1996;124:306-14.
14. Levesque D, Diaz J, Pilon C, Martres M, Giros B, Souil E, Schott D, Morgat J, Schwartz J, Sokoloff P. Identification, characterization and localization of the dopamine D3 receptor in the rat brain using 7-[3H]-hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc Natl Acad Sci 1992;89:8155-9.
15. McElroy JF. Discriminative stimulus properties of 7-OH-DPAT, a dopamine D3-selective receptor ligand. Pharmacol Biochem Behav 1994;48: 531-3.
16. Mohell N, Sällemark M, Rosqvist S, Malmberg Å, Högberg T, Jackson DM. Binding characteristics of remoxipride and its metabolites to dopamine D2 and D3 receptors. Eur J Pharmacol 1993;238:121-5.
17. Pugsley TA, Davis MD, Akunne HC, MacKenzie RG, Shih YH, Damsma G, Wikstrom H, Whetzel SZ, Georgie LM, Cooke LW, DeMattos SB, Corbin AE, Glase SA, Wise LD, Dijkstra D, Heffner TG. Neurochemical and functional characterization of the preferentially selective D3 agonist PD 128907. J Pharmacol Exp Ther 1995;275:1355-66.
18. Sanger DJ, Depoortere R. Discriminative stimulus effects of apormorphine and 7-OH-DPAT: a potential role for dopamine D3 receptors. Psychopharmacology 1997;130:387-95.
19. Sautel F, Griffon N, Levesque D, Pilon C, Schwartz JC, Sokoloff P. A functional test identifies dopamine agonist selective for D3 vs. D2 receptors. NeuroReport 1995;6:329-32.
20. Sibley DR, Monsma JR. Molecular biology of dopamine receptors. Trends Pharmacol Sci 1992;13:61-9.
21. Spealman RD. Dopamine D3 receptor agonists partially reproduce the discriminative effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther 1996;278:1128-37.
22. Varty GB, Higgins GA. Investigation into the nature of a 7-OH-DPAT discriminative cue: comparison with D-amphetamine. Eur J Pharmacol 1997;339:101-7.